ESC 365 - Multi-center, prospective, registry-based nationwide study of the (cost-)effectiveness of telemedicine in heart failure patients in the Netherlands - design and recruitment of the RELEASE-HF study.

HFA Premium Access

Multi-center, prospective, registry-based nationwide study of the (cost-)effectiveness of telemedicine in heart failure patients in the Netherlands - design and recruitment of the RELEASE-HF study.

Session: Heart Failure ePosters - focus on Pharmacology and other topics

Topic: Remote Patient Monitoring and Telehealth

Speaker: Ms J. van Eijk (Utrecht, NL)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Ms Jorna van Eijk

Utrecht (Netherlands (The))

0 follower

30 more presentations in this session

Efficacy and safety of sacubitril/valsartan (LCZ696) in reducing adverse cardiovascular events and controlling hypertension among asians: a meta-analysis of randomised controlled trials

Speaker: Doctor P. Vera Cruz (Quezon, PH)

Role of empagliflozin in diabetic patient with acute myocardial infarction who undergone percutaneous coronary intervention

Recovery of left ventricular ejection fraction in patients treated with sacubitril/valsartan

Speaker: Doctor J. Mesquita Guimaraes (Coimbra, PT)

Levosimendan bridge to therapy optimization

Speaker: Doctor C. Moliner-Abos (Barcelona, ES)

ORal anti-coagulants In fraGile patients with percutAneous endoscopic gastrostoMy and atrIal fibrillation: the ORIGAMI pilot investigation

Speaker: Doctor D. D'Amario (Novara, IT)

Access the full session

Heart Failure ePosters - focus on Pharmacology and other topics

Speakers: Ms J. van Eijk, Doctor P. Vera Cruz, Doctor J. Mesquita Guimaraes, Doctor C. Moliner-Abos, Doctor D. D'Amario

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources